Eastman Chemical Company filings document regulatory disclosures for a global specialty materials issuer with publicly traded common stock and outstanding debt securities. Form 8-K reports furnish quarterly and annual operating results, including sales, EBIT, cash flow, segment performance, price-cost conditions, raw-material pressures and updates tied to specialty businesses and methanolysis assets.
Proxy materials describe director elections, board committee matters, executive compensation, say-on-pay voting and shareholder proposals. Other material-event filings record debt issuance under registration statements and indentures, officer and director changes, compensatory arrangements, common stock references and note terms, including interest, maturity and redemption provisions.
Eastman Chemical Company (EMN) reported third-quarter 2026 sales of $2.385 billion, up 8% from $2.202 billion, and net earnings attributable to Eastman of $252 million versus $69 million a year earlier. Diluted earnings per share were $2.19, compared with $0.60. Higher selling prices and sales volume mix supported sales; higher prices primarily reflected raw material and distribution costs and tight market conditions in Chemical Intermediates. The quarter’s income-tax provision included a $61 million reduction in unrecognized tax benefits, inclusive of related interest.
For the first nine months, sales were $7.075 billion versus $6.779 billion, and net earnings attributable to Eastman were $542 million versus $391 million. Operating cash flow was $377 million, compared with $468 million in the prior-year period. Third-quarter earnings before interest and taxes were $305 million versus $188 million.
Eastman issued $600 million aggregate principal amount of 4.5% notes due February 2031 in first-quarter 2026; net proceeds were $594 million. It repaid the remaining $150 million balance of its 2027 Term Loan using available cash. At September 30, 2026, cash and cash equivalents were $768 million and total borrowings were $5.218 billion.
Eastman Chemical Company reported third-quarter 2026 sales revenue of $2.385 billion, up 8% from $2.202 billion a year earlier; the increase reflected 7% higher selling prices and 1% higher sales volume/mix. Earnings before interest and taxes were $305 million, versus $188 million, and earnings per diluted share were $2.19, versus $0.60. Adjusted earnings per diluted share, a non-GAAP measure, were $1.84, compared with $1.14.
Net cash provided by operating activities was $290 million, down from $402 million in third-quarter 2025; first-nine-month operating cash flow was $377 million, versus $468 million. Additives & Functional Products and Chemical Intermediates reported higher EBIT, while Fibers reported lower EBIT. Eastman announced reinstatement of a $375 million U.S. Department of Energy award supporting circular-platform scale-up and said it remains on track to deliver $125 million to $150 million of 2026 cost savings, net of inflation.
For full-year 2026, Eastman projects adjusted earnings per share of $6.00 to $6.20 and operating cash flow of approximately $850 million. It also expects sequential demand declines with normal seasonality and some additional customer caution.
Eastman Chemical Company (EMN) adopted amended and restated bylaws effective October 16, 2026. The changes revise procedures and disclosure requirements for stockholder-requested special meetings, director nominations and other business proposals, and establish separate notice windows for proxy access nominations. Director candidates must make themselves available for interviews, and contested director elections will use a plurality voting standard. The bylaws also clarify that the exclusive forum provision does not cover claims under the Securities Exchange Act or other claims within the exclusive jurisdiction of U.S. federal district courts.
For EMN’s 2027 annual meeting, notices of nominations or other business outside Rule 14a-8 and proxy access must be delivered from January 7, 2027, through February 6, 2027, subject to alternative timing if the meeting date changes by more than the specified period. The Rule 14a-8 proposal deadline remains November 24, 2026; the proxy-access nomination window is October 25 through November 24, 2026.
Eastman Chemical Co. director Linnie M. Haynesworth acquired 480 Phantom Stock Units on October 7, 2026, through automatic deferral of part of her annual retainer that otherwise would have been paid in cash. Her reported total after the credit was 6,405 Phantom Stock Units, including units credited through dividend-equivalent reinvestments under the Directors' Deferred Compensation Plan.
Eastman Chemical Co. director Eric L. Butler acquired 480 Phantom Stock Units on October 7, 2026, through automatic deferral of part of his annual retainer that otherwise would have been paid in cash. Each unit has a value equal to one share of common stock and is payable only in cash after termination of service as a director. His reported balance was 3,798 units after the transaction, including units credited since April 8, 2026, as reinvestment of dividend equivalents.
Eastman Chemical Co. director Donald W. Slager acquired 480 Phantom Stock Units on October 7, 2026, through automatic deferral of part of his annual retainer that otherwise would have been paid in cash. His reported post-transaction balance was 2,227 units, including units credited since April 8, 2026, as reinvestment of dividend equivalents for deferred phantom shares.
Eastman Chemical Co. (EMN) director Brett D. Begemann reported two direct acquisitions of Phantom Stock Units on October 7, 2026: 1,362 units reported at $63.25 per unit through voluntary deferral of retainer fees, and 480 units through automatic deferral of part of annual retainer fees. The units track the market value of one common share and are payable only in cash after director service ends; both entries include dividend-equivalent credits.
On October 7, 2026, Eastman Chemical Co. (EMN) director Damon J. Audia acquired 1,002 Phantom Stock Units, reported at $63.25 per unit, through voluntary deferral of part of his retainer; the units include reinvested dividend equivalents. He also acquired 480 units through automatic deferral of part of his annual retainer. Each unit has a value equal to the market value of one Eastman common share and is payable only in cash after his service as a director ends.
Julie Fasone Holder reported acquisition or exercise transactions in this Form 4 filing. Eastman Chemical director Julie Fasone Holder had 480 Phantom Stock Units credited on October 7, 2026, through automatic deferral of part of her annual retainer fees that otherwise would have been paid in cash. Each unit has a value equal to the market value of one share of Eastman Chemical common stock and is payable only in cash after termination of service as a director. Her reported balance after the credit was 15,948 units, including units credited since April 8, 2026, as reinvestment of dividend equivalents.
Eastman Chemical Co. director Kim Ann Mink acquired 480 Phantom Stock Units on October 7, 2026, through an automatic deferral of part of her annual retainer that otherwise would have been paid in cash. Each unit has a value equal to the market value of one common share and is payable only in cash after termination of director service. Her reported resulting balance was 18,409 Phantom Stock Units.